Early Paxil Competitor? FDA Approves Synthon’s Paroxetine 505(b)(2)

Synthon will enter the Paxil market in the fourth quarter with the launch of its paroxetine mesylate product

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet